FDA Hammers Active Ingredient Maker Over 'Severe Hazard'

Law360, New York (February 12, 2014, 6:13 PM EST) -- A manufacturer of active pharmaceutical ingredients created a “severe hazard” by adopting substandard labeling and storage practices at plants in Arizona and Hong Kong, according to a U.S. Food and Drug Administration warning letter released Wednesday.

In one of the most notable findings, the FDA said that it encountered a container whose labels indicated the presence of an inactive ingredient, but that testing of the contents revealed a variety of different substances used to treat medical conditions.

“The unacceptable practices that resulted in this mislabeling incident...
To view the full article, register now.